Table 1 Demographic and clinical features of entire cohort, subgroups A and B.
From: Long-COVID autonomic syndrome in working age and work ability impairment
Demographic and clinical features | Entire cohort (N = 45) | Subgroup A (N = 15) | Subgroup B (N = 30) |
|---|---|---|---|
Age (years) | 53.6 ± 8.4 | 52.8 ± 9.4 | 54.1 ± 8.1 |
Sex M/F | 32/13 | 10/5 | 22/8 |
BMI (kg/m2) | 28.3 ± 4.0 | 28.3 ± 3.95 | 28.4 ± 4.1 |
Comorbidities (%) | |||
 Hypertension | 6 (13) | 3 (20) | 3 (10) |
 Structural heart disease | 0 (0) | 0 (0) | 0 (0) |
 Arrythmias | 1 (2) | 1 (7) | 0 (0) |
 Cerebrovascular disease | 1 (2) | 1 (7) | 0 (0) |
 Neurological disease | 1 (2) | 0 (0) | 1 (3) |
 Diabetes mellitus | 6 (13) | 1 (7) | 5 (17) |
 COPD | 0 (0) | 0 (0) | 0 (0) |
 Neoplasm | 3 (7) | 0 (0) | 3 (10) |
 Other | 15 (33) | 2 (13) | 4 (13) |
Medical therapy (%) | |||
 Beta blockers | 8 (18) | 3 (20) | 5 (17) |
 ACE-I or ARB | 5 (11) | 1 (7) | 4 (13) |
 Statins | 6 (13) | 2 (13) | 4 (13) |
 Anticoagulation | 5 (11) | 1 (7) | 4 (13) |
 Anti-platelet | 2 (4) | 0 (0) | 2 (7) |
 Calcium channel blockers | 6 (13) | 2 (13) | 4 (13) |
 Diuretic | 1 (2) | 0 (0) | 1 (3) |
 Diabetes drugs | 6 (13) | 1 (7) | 5 (17) |
 Proton pump inhibitors | 10 (22) | 1 (7) | 9 (30) |
 NSAIDs | 5 (11) | 2 (13) | 3 (10) |
 Corticosteroids | 5 (11) | 2 (13) | 3 (10) |
 Anti-arrhythmic | 0 (0) | 0 (0) | 0 (0) |
 Other | 8 (18) | 3 (20) | 6 (20) |
Hospital stays (%) | |||
 Length of stay > 14 days | 10 (22) | 3 (20) | 7 (23) |
 Length of stay > 20 days | 5 (11) | 1 (7) | 5 (17) |
 ICU admission | 6 (13) | 1 (7) | 5 (17) |
Job task demand (%) | |||
 Prevalent mental | 24(53) | 9(60) | 15(50) |
 Prevalent physical | 7 (15) | 3(20) | 4(13) |
 Mental/physical | 14(30) | 3(20) | 11(37) |
